Inspire™ Family of Adult Oxygenators

1. INDICATIONS FOR USE / INTENDED PURPOSE 

Inspire Oxygenator (Models: Inspire 6, Inspire 7, Inspire 8)  

The devices are indicated for adult and small adult patients undergoing surgical procedures requiring cardiopulmonary bypass 

The devices are extracorporeal circulation devices used to replace the patient respiratory function during cardiopulmonary bypass procedures. They are used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood, and to cool or warm the blood during cardiopulmonary bypass procedures. 

The devices must be to be used up to 6 hours or less. 

Inspire Oxygenator with integrated arterial filter (Models: Inspire 6F, Inspire 7F, Inspire 8F)  

The devices are indicated for adult and small adult patients undergoing surgical procedures requiring cardiopulmonary bypass. 

The devices are extracorporeal circulation devices used to replace the patient respiratory function during cardiopulmonary bypass procedures. They are used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood, and to cool or warm the blood during cardiopulmonary bypass procedures. 

The integrated arterial filter provides filtration against air and solid emboli. 

The devices must be to be used up to 6 hours or less. 

Inspire Cardiotomy/venous reservoir (Models HVR, and HVR dual) 

The devices are indicated for adult and small adult patients undergoing surgical procedures requiring cardiopulmonary bypass. 

The devices are extracorporeal circulation devices allowing oxygenators to exploit gas exchange for the replacement of patient respiratory function during cardiopulmonary bypass procedures., providing dynamic patient’s venous blood collection. They also defoam and filter venous blood and suction blood through a filtering system made of antifoam agent and filter screen. Can be used post-operatively for chest drainage.   

The devices must be to be used up to 6 hours or less. 

2. CONTRAINDICATIONS 

No contraindications are known if the device is used for the purpose described and in accordance with the stated operating conditions. Do not use the device for any purpose other than indicated. 

3. WARNINGS  

The device must be used in accordance with the instructions for use provided in the Instructions for Use. . For a complete listing of warnings please refer to the Instructions for Use which accompany each product 

4. PRECAUTIONS  

Federal law (U.S.A.) restricts this device to sale by or on the order of a physician. For a complete listing of precautions/cautions please refer to the Instructions for Use which accompany each product 

5. ADVERSE EVENTS 

The following table summarizes harms potentially arising during the use of the medical device, including those related to the intrinsic risks of extracorporeal circulation:. Systemic Inflammatory Response Syndrome (SIRS), Hypoperfusion / Hypoxia, Embolism / Hypovolemia / Sepsis / Infection / Fever / Shock/ Allergic reactions / Cyto-toxic reactions / Genetic mutation / Cancer / Haemolysis / Organ damage / Acid base imbalance (only for oxygenator) / Cross contamination / User contamination / Environment contamination / Thrombosis / Impaired hemostasis / Blood activation / Bleeding / User skin tears and  Pneumothorax (only for cardiotomy/venous reservoir)  

6. PERFORMANCE INFORMATION 

The devices are designed to come into contact with patient blood and are single use, non-toxic, non-pyrogenic, supplied sterile in individual packaging. Sterilised by ethylene oxide. The level of ethylene oxide residuals in the device is within the limits established by national regulations in the country of use. 

The devices should be used by qualified and skilled personnel, able to follow the indications and instructions for use contained in the information provided by the manufacturer. Please contact us through our website (www.sorinmanuals.com) to receive instructions for use containing full prescribing information including indications, contraindications, warnings, precautions and adverse events.  

The information contained in this summary represents partial excerpts taken from the product labeling. The information is not intended to serve as a substitute for a complete and through understanding of the device nor does this information represent full disclosure of all pertinent information concerning the use of this product. Not approved in al geographies. Consult your labeling. 

Legal Manufacturer:
Sorin group italia S.r.l.
Via Statale 12 Nord, 86
Mirandola (MO) Italy

1. Habib et all- Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed- The Journal of Thoracic and Cardiovascular Surgery - June 2003 

2. Ranucci M et al., Effects of priming volume reduction on allogeneic red blood cell transfusions and renal outcome after heart surgery. Perfusion 3/2015;Volume: 30: 2:120-126 

3. Stehouwer MC et al., Effect of Oxygenator Size on Air Removal Characteristics: A Clinical Evaluation.ASAIO J. 2016 Jul-Aug 

4. De Somer F et al. Phosphorylcholine coating of extracorporeal circuits provides natural  protection against blood activation by the material surface. Eur J Cardiothorac Surg 2000;18:602–6 

5. Shann KG et al., An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 2006;132:283–90 

6. Albes JM,  et al. Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating. J Thorac Cardiovasc Surg 2003;126:1504–12 

Technical claims supported by LivaNova data on file